Patents by Inventor Mark Weinberg

Mark Weinberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF TNF ALPHA INHIBITOR
    Publication number: 20190062418
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: March 14, 2018
    Publication date: February 28, 2019
    Inventors: Rebecca S. Hoffman, Mark Weinberg
  • Use of TNFalpha Inhibitor
    Publication number: 20160376360
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: July 27, 2015
    Publication date: December 29, 2016
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Elliot K. Chartash, Philip Yan, George R. Granneman
  • Use of TNF? inhibitor
    Patent number: 9512216
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: December 6, 2016
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Elliot K. Chartash, Philip Yan, George R. Granneman
  • Uses and Compositions for Treatment of Psoriatic Arthritis
    Publication number: 20160297879
    Abstract: The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of psoriatic arthritis in a subject.
    Type: Application
    Filed: November 18, 2015
    Publication date: October 13, 2016
    Inventors: Rebecca S. Hoffman, Eric H. Sasso, Renee J. Perdok, Philip Yan, Mark Weinberg, Philip Mease, Christopher T. Ritchlin, Dafna D. Gladman
  • Use of TNFalpha Inhibitor
    Publication number: 20160272704
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: June 3, 2016
    Publication date: September 22, 2016
    Inventors: Rebecca S. Hoffman, Mark Weinberg
  • Use of TNFalpha Inhibitor
    Publication number: 20160176957
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: July 27, 2015
    Publication date: June 23, 2016
    Inventors: Rebecca S. Hoffman, Mark Weinberg
  • System, method, and computer program for generating channel specific heuristics
    Patent number: 9195961
    Abstract: A system, method, and computer program product are provided for generating channel specific heuristics. In use, at least one channel filter including a characteristic associated with a communications channel is identified. Additionally, the at least one channel filter is applied to at least one design heuristic. Furthermore, at least one channel specific heuristic is generated based on the application of the at least one channel filter to the at least one design heuristic.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: November 24, 2015
    Assignee: Amdocs Software Systems Limited
    Inventors: Mark Weinberg, Dov Rosner
  • USE OF TNFALPHA INHIBITOR FOR TREATMENT OF PSORIATIC ARTHRITIS
    Publication number: 20150218269
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: April 8, 2015
    Publication date: August 6, 2015
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • Use of TNFalpha Inhibitor for Treatment of Psoriasis
    Publication number: 20150218268
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: April 8, 2015
    Publication date: August 6, 2015
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • Use of TNF? inhibitor for treatment of psoriasis
    Patent number: 9090689
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: July 28, 2015
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • Use of TNF? inhibitor for treatment of psoriatic arthritis
    Patent number: 9085620
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: July 21, 2015
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • Use of TNF? inhibitor for treatment of psoriatic arthritis
    Patent number: 9067992
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: June 30, 2015
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg
  • Use of TNFalpha Inhibitor for Treatment of Erosive Polyarthritis
    Publication number: 20150086569
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: December 8, 2014
    Publication date: March 26, 2015
    Inventors: REBECCA S. HOFFMAN, MARK WEINBERG
  • Use of TNF? inhibitor for treatment of psoriasis
    Patent number: 8986693
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: March 24, 2015
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Elliot K. Chartash, Philip Yan, George R. Granneman
  • Use of TNFAlpha Inhibitor for Treatment of Psoriasis
    Publication number: 20150071938
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: October 9, 2014
    Publication date: March 12, 2015
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Elliot K. Chartash, Philip Yan, George R. Granneman
  • Use of TNF-alpha inhibitor for treatment of psoriasis
    Patent number: 8906373
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: December 9, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • USE OF TNFALPHA INHIBITOR FOR TREATMENT OF EROSIVE POLYARTHRITIS
    Publication number: 20140286867
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: April 30, 2014
    Publication date: September 25, 2014
    Inventors: Rebecca S. Hoffman, Mark Weinberg
  • USES AND COMPOSITIONS FOR TREATMENT OF PSORIATIC ARTHRITIS
    Publication number: 20140248215
    Abstract: The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of psoriatic arthritis in a subject.
    Type: Application
    Filed: August 26, 2013
    Publication date: September 4, 2014
    Inventors: Rebecca S. Hoffman, Eric H. Sasso, Renee J. Perdok, Philip Yan, Mark Weinberg, Phillip Mease, Christopher T. Ritchlin, Dafna D. Gladman
  • USE OF TNF ALPHA INHIBITOR FOR TREATMENT OF EROSIVE POLYARTHRITIS
    Publication number: 20140234222
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: March 28, 2014
    Publication date: August 21, 2014
    Applicant: AbbVie Biotechnology, Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg
  • Use of TNF alpha inhibitor for treatment of erosive polyarthritis
    Patent number: 8808700
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: August 19, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Mark Weinberg